Datametrex Announces Investor Webinar

TORONTO - February 3, 2021 - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to announce that senior management will be hosting an investor update webinar on Tuesday, February 9, 2021, at 1:30 p.m. EST for a corporate update on the latest developments of the Artificial Intelligence technologies and COVID-19 test kits.


Webinar Details:


Date: Tuesday, February 9, 2021

Time: 1:30 p.m. ET

Registration Link: https://us02web.zoom.us/webinar/register/WN_Ge6setHBRAyeBLbKaUIUHQ


Datametrex plans to answer questions previously sent to support@datametrex.com and during the webinar, at management's discretion and subject to time constraints.


About Datametrex


Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.

For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.


For further information, please contact:


Marshall Gunter - CEO Phone: (514) 295-2300 Email: mgunter@datametrex.com


Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Forward-Looking Statements:

All statements included in this press release that address activities, events, or developments that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company's control. In particular, there is no guarantee that the parties will successfully negotiate and enter into a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if at all, that the due diligence of any of the parties will be satisfactory, or that the parties will obtain any required board, shareholder, third-party and/or regulatory or other governmental approvals, if any. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

Recent Posts

See All

Datametrex Completed 62,000 COVID-19 Tests in Q2

Toronto, Ontario--(Newsfile Corp. - July 8, 2021) - Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce that the Company conducted approxi